trial · primary record
JNJ-68284528
Multiple Myeloma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 208 |
| Primary completion | 2028-08-25 |
| Primary endpoint | Cohorts A, B, C, D, E, and F: Percentage of Participants with Negative Minimal Residual Disease (MRD) |
| Registry ID | NCT04133636 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:39.519Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04133636
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.